We are live on ! Find out more
O

Ossiam Portfolio holdings

AUM $5.69B
1-Year Est. Return 30.95%
This Fund
S&P 500
This Quarter Est. Return
+8.43%
1 Year Est. Return
+30.95%
3 Year Est. Return
+104.81%
5 Year Est. Return
+127.55%
10 Year Est. Return
AUM
$1.31B
AUM Growth
-$122M
Cap. Flow
-$203M
Cap. Flow %
-15.51%
Top 10 Hldgs %
37.2%
Holding
529
New
58
Increased
189
Reduced
228
Closed
54

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$55.6M
2
MA icon
Mastercard
MA
+$42M
3
PG icon
Procter & Gamble
PG
+$37.7M
4
T icon
AT&T
T
+$36.5M
5
AMGN icon
Amgen
AMGN
+$28.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$71.9M
2
WFC icon
Wells Fargo
WFC
+$50.4M
3
LIN icon
Linde
LIN
+$39.2M
4
DIS icon
Walt Disney
DIS
+$39M
5
CVS icon
CVS Health
CVS
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 23.16%
2 Communication Services 14.07%
3 Healthcare 13.47%
4 Financials 12.21%
5 Consumer Staples 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$78.6M 5.99%
1,070,132
+328,220
+44% +$21.1M
JNJ icon
2
Johnson & Johnson
JNJ
$635B
$60.5M 4.61%
414,572
+410,072
+9,113% +$55.6M
MSFT icon
3
Microsoft
MSFT
$2.84T
$59.9M 4.56%
379,636
+10,826
+3% +$1.59M
PG icon
4
Procter & Gamble
PG
$343B
$52.2M 3.98%
418,177
+308,485
+281% +$37.7M
T icon
5
AT&T
T
$165B
$49.2M 3.75%
1,667,640
+1,264,576
+314% +$36.5M
MA icon
6
Mastercard
MA
$477B
$44.6M 3.4%
149,351
+148,971
+39,203% +$42M
META icon
7
Meta Platforms (Facebook)
META
$1.51T
$41.1M 3.13%
200,190
-74,594
-27% -$14.4M
IBM icon
8
IBM
IBM
$202B
$40.5M 3.08%
315,667
-77,870
-20% -$10.1M
AMGN icon
9
Amgen
AMGN
$203B
$31.5M 2.41%
130,845
+130,396
+29,041% +$28.7M
PFE icon
10
Pfizer
PFE
$140B
$29.9M 2.28%
804,032
+227,196
+39% +$8.09M
AMZN icon
11
Amazon
AMZN
$2.5T
$28.7M 2.19%
310,400
-198,260
-39% -$17.5M
UBS icon
12
UBS Group
UBS
$170B
$25.2M 1.93%
2,000,000
-799,990
-29% -$9.51M
INTC icon
13
Intel
INTC
$466B
$18.7M 1.43%
312,553
+232,399
+290% +$13M
NEM icon
14
Newmont
NEM
$98.2B
$18.5M 1.41%
424,718
-55,774
-12% -$2.18M
ELV icon
15
Elevance Health
ELV
$81.9B
$16.9M 1.29%
55,963
+49,512
+768% +$13.6M
BAC icon
16
Bank of America
BAC
$435B
$16.5M 1.26%
469,494
+421,967
+888% +$13.6M
VZ icon
17
Verizon
VZ
$194B
$16M 1.22%
261,045
+114,705
+78% +$6.92M
AZO icon
18
AutoZone
AZO
$48.3B
$15.6M 1.19%
13,092
+2,203
+20% +$2.54M
SYY icon
19
Sysco
SYY
$39.7B
$15.4M 1.17%
179,555
+103,227
+135% +$8.36M
TWTR
20
DELISTED
Twitter, Inc.
TWTR
$15.1M 1.15%
472,205
+415,953
+739% +$13.7M
AVGO icon
21
Broadcom
AVGO
$1.82T
$15M 1.15%
475,950
-1,048,800
-69% -$31.8M
ALC icon
22
Alcon
ALC
$33.1B
$14.8M 1.13%
+260,957
New +$14.9M
TXN icon
23
Texas Instruments
TXN
$255B
$14.3M 1.09%
111,217
-19,133
-15% -$2.36M
GOOGL icon
24
Alphabet (Google) Class A
GOOGL
$3.91T
$14.2M 1.08%
212,220
+187,840
+770% +$12.1M
WMT icon
25
Walmart Inc
WMT
$871B
$12M 0.92%
303,240
-511,893
-63% -$20.3M

Similar funds

Ossiam's Q4 2019 Portfolio in Review

As of Q4 2019, Ossiam held 529 positions worth $1.31B, down 8.5% from $1.43B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Ossiam withdrew a net $203M in Q4 2019, closing 54 positions and reducing 228 holdings. Its most notable exit was Celgene Corp, an estimated $71.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Ossiam opened a new position in Alcon worth $14.8M.

  • Ossiam's largest Q4 2019 buy was Alcon: 260,957 shares worth $14.8M.
  • Ossiam added most to Johnson & Johnson in Q4 2019, an estimated $55.6M increase.
  • Ossiam's biggest Q4 2019 reduction was Linde, cutting an estimated $39.2M.
  • Ossiam fully exited Celgene Corp in Q4 2019, selling an estimated $71.9M.
  • Ossiam's ten largest holdings make up 37% of its $1.31B portfolio in Q4 2019.
  • Ossiam opened 58 new positions and closed 54 in Q4 2019.
  • Ossiam's portfolio value fell 8.5% quarter-over-quarter to $1.31B.

Based on Ossiam's 13F filing for Q4 2019, filed 14 Feb 2020.